Freedom Laser Therapy, Inc.

NEW YORK, Nov. 1, 2022 /PRNewswire/ -- The benign prostatic hyperplasia (BPH) devices market size is expected to grow by USD 3.34 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.09% during the forecast period, according to Technavio. The increasing prevalence of BPH coupled with increasing risk factors is driving the benign prostatic hyperplasia (BPH) devices market growth. However, factors such as the high cost of BPH treatment may challenge the market growth Continue Reading Technavio has announced its latest market research report titled Global Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026 View a comprehensive report summary that describes the market size and forecast along with the research methodology. The FREE sample report is available in PDF format Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Scope The benign prostatic hyperplasia (BPH) devices market report covers the following areas: Benign Prostatic Hyperplasia (BPH) Devices Market size Benign Prostatic Hyperplasia (BPH) Devices Market trends Benign Prostatic Hyperplasia (BPH) Devices Market industry analysis Subscribe to our "Basic Plan" billed annually at USD 5000 that enables you to download 5 reports and view 100 reports per month Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Segmentation Benign Prostatic Hyperplasia (BPH) Devices Market is segmented as below: Therapy TURP Laser Therapy Others The benign prostatic hyperplasia (BPH) devices market share growth by the TURP segment will be significant during the forecast period. TURP is considered a standard treatment for BPH by many organizations such as the American Urological Association (AMA), Canadian Urological Association (CUA), and European Urological Association (EAU). It is efficient, cost-effective, and durable with low long-term complications and re-treatment rates. The increasing preference for B-TURP for BPH treatment is expected to drive the TURP devices segment, which will fuel the growth of the market in focus during the forecast years. Geography North America Europe Asia Rest Of World (ROW) 37% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for benign prostatic hyperplasia (BPH) devices in North America. The growing elderly population, rising incidence of BPH, and perpetual innovations in BPH devices will facilitate the benign prostatic hyperplasia (BPH) devices market growth in North America over the forecast period. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Vendor Analysis We provide a detailed analysis of around 25 vendors operating in the benign prostatic hyperplasia (BPH) devices market, including Astellas Pharma Inc., biolitec AG, Boston Scientific Corp., Butterfly Medical, Coloplast AS, Convergent Laser Technologies, IPG Photonics Corp., KARL STORZ SE and Co. KG, Medeon Biodesign Inc., Medifocus Inc., Olympus Europa SE and Co. KG, OmniGuide Holdings Inc., ProArc Medical, PROCEPT BioRobotics Corp., Richard Wolf GmbH, SRS Medical, Teleflex Inc., Urologix LLC, Vendor Credentialing Service LLC dba symplr, and Zenflow Inc. This report provides a full list of key vendors, their strategies, and the latest developments. Buy Now for detailed vendor information Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Key Highlights CAGR of the market during the forecast period 2022-2026 Detailed information on factors that will assist benign prostatic hyperplasia (BPH) devices market growth during the next five years Estimation of the benign prostatic hyperplasia (BPH) devices market size and its contribution to the parent market Predictions on upcoming trends and changes in consumer behavior The growth of the benign prostatic hyperplasia (BPH) devices market Analysis of the market's competitive landscape and detailed information on vendors Comprehensive details of factors that will challenge the growth of benign prostatic hyperplasia (BPH) devices market vendors Related Reports: Cardiovascular Medical Devices Market by Product and Geography – Forecast and Analysis 2022-2026: The cardiovascular medical devices market share is expected to increase by USD 24.51 billion from 2021 to 2026. Medical Devices Market by Product and Geography – Forecast and Analysis 2022-2026: The medical devices market share is expected to increase by USD 155.43 billion from 2021 to 2026. Table Of Contents : 1 Executive Summary 1.1 Market Overview Exhibit 01: Executive Summary – Chart on Market Overview Exhibit 02: Executive Summary – Data Table on Market Overview Exhibit 03: Executive Summary – Chart on Global Market Characteristics Exhibit 04: Executive Summary – Chart on Market by Geography Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapy Exhibit 06: Executive Summary – Chart on Incremental Growth Exhibit 07: Executive Summary – Data Table on Incremental Growth Exhibit 08: Executive Summary – Chart on Vendor Market Positioning 2 Market Landscape 2.1 Market ecosystem Exhibit 09: Parent market Exhibit 10: Market Characteristics 3 Market Sizing 3.1 Market Definition Exhibit 11: Offerings of vendors included in the market definition 3.2 Market segment analysis Exhibit 12: Market segments 3.3 Market size 2021 3.4 Market outlook: Forecast for 2021-2026 Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million) Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million) Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%) Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%) 4 Five Forces Analysis 4.1 Five forces summary Exhibit 17: Five forces analysis - Comparison between 2021 and 2026 4.2 Bargaining power of buyers Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026 4.3 Bargaining power of suppliers Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026 4.4 Threat of new entrants Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026 4.5 Threat of substitutes Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026 4.6 Threat of rivalry Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026 4.7 Market condition Exhibit 23: Chart on Market condition - Five forces 2021 and 2026 5 Market Segmentation by Therapy 5.1 Market segments Exhibit 24: Chart on Therapy - Market share 2021-2026 (%) Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%) 5.2 Comparison by Therapy Exhibit 26: Chart on Comparison by Therapy Exhibit 27: Data Table on Comparison by Therapy 5.3 TURP - Market size and forecast 2021-2026 Exhibit 28: Chart on TURP - Market size and forecast 2021-2026 ($ million) Exhibit 29: Data Table on TURP - Market size and forecast 2021-2026 ($ million) Exhibit 30: Chart on TURP - Year-over-year growth 2021-2026 (%) Exhibit 31: Data Table on TURP - Year-over-year growth 2021-2026 (%) 5.4 Laser therapy - Market size and forecast 2021-2026 Exhibit 32: Chart on Laser therapy - Market size and forecast 2021-2026 ($ million) Exhibit 33: Data Table on Laser therapy - Market size and forecast 2021-2026 ($ million) Exhibit 34: Chart on Laser therapy - Year-over-year growth 2021-2026 (%) Exhibit 35: Data Table on Laser therapy - Year-over-year growth 2021-2026 (%) 5.5 Others - Market size and forecast 2021-2026 Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million) Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million) Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%) Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%) 5.6 Market opportunity by Therapy Exhibit 40: Market opportunity by Therapy ($ million) 6 Customer Landscape 6.1 Customer landscape overview Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 7 Geographic Landscape 7.1 Geographic segmentation Exhibit 42: Chart on Market share by geography 2021-2026 (%) Exhibit 43: Data Table on Market share by geography 2021-2026 (%) 7.2 Geographic comparison Exhibit 44: Chart on Geographic comparison Exhibit 45: Data Table on Geographic comparison 7.3 North America - Market size and forecast 2021-2026 Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million) Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million) Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%) Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%) 7.4 Europe - Market size and forecast 2021-2026 Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million) Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million) Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%) Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%) 7.5 Asia - Market size and forecast 2021-2026 Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million) Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million) Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%) Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%) 7.6 Rest of World (ROW) - Market size and forecast 2021-2026 Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) 7.7 US - Market size and forecast 2021-2026 Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million) Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million) Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%) Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%) 7.8 France - Market size and forecast 2021-2026 Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million) Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million) Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%) Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%) 7.9 China - Market size and forecast 2021-2026 Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million) Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million) Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%) Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%) 7.10 Ireland - Market size and forecast 2021-2026 Exhibit 74: Chart on Ireland - Market size and forecast 2021-2026 ($ million) Exhibit 75: Data Table on Ireland - Market size and forecast 2021-2026 ($ million) Exhibit 76: Chart on Ireland - Year-over-year growth 2021-2026 (%) Exhibit 77: Data Table on Ireland - Year-over-year growth 2021-2026 (%) 7.11 Canada - Market size and forecast 2021-2026 Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million) Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million) Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%) Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%) 7.12 Market opportunity by geography Exhibit 82: Market opportunity by geography ($ million) 8 Drivers, Challenges, and Trends 8.1 Market drivers 8.2 Market challenges 8.3 Impact of drivers and challenges Exhibit 83: Impact of drivers and challenges in 2021 and 2026 8.4 Market trends 9 Vendor Landscape 9.1 Overview 9.2 Vendor landscape Exhibit 84: Overview on Criticality of inputs and Factors of differentiation 9.3 Landscape disruption Exhibit 85: Overview on factors of disruption 9.4 Industry risks Exhibit 86: Impact of key risks on business 10 Vendor Analysis 10.1 Vendors covered Exhibit 87: Vendors covered 10.2 Market positioning of vendors Exhibit 88: Matrix on vendor position and classification 10.3 Boston Scientific Corp. Exhibit 89: Boston Scientific Corp. - Overview Exhibit 90: Boston Scientific Corp. - Business segments Exhibit 91: Boston Scientific Corp. - Key news Exhibit 92: Boston Scientific Corp. - Key offerings Exhibit 93: Boston Scientific Corp. - Segment focus 10.4 Convergent Laser Technologies Exhibit 94: Convergent Laser Technologies - Overview Exhibit 95: Convergent Laser Technologies - Product / Service Exhibit 96: Convergent Laser Technologies - Key offerings 10.5 KARL STORZ SE and Co. KG Exhibit 97: KARL STORZ SE and Co. KG - Overview Exhibit 98: KARL STORZ SE and Co. KG - Product / Service Exhibit 99: KARL STORZ SE and Co. KG - Key news Exhibit 100: KARL STORZ SE and Co. KG - Key offerings 10.6 Medifocus Inc. Exhibit 101: Medifocus Inc. - Overview Exhibit 102: Medifocus Inc. - Product / Service Exhibit 103: Medifocus Inc. - Key offerings 10.7 Olympus Europa SE and Co. KG Exhibit 104: Olympus Europa SE and Co. KG - Overview Exhibit 105: Olympus Europa SE and Co. KG - Product / Service Exhibit 106: Olympus Europa SE and Co. KG - Key offerings 10.8 OmniGuide Holdings Inc. Exhibit 107: OmniGuide Holdings Inc. - Overview Exhibit 108: OmniGuide Holdings Inc. - Product / Service Exhibit 109: OmniGuide Holdings Inc. - Key offerings 10.9 Richard Wolf GmbH Exhibit 110: Richard Wolf GmbH - Overview Exhibit 111: Richard Wolf GmbH - Product / Service Exhibit 112: Richard Wolf GmbH - Key offerings 10.10 Teleflex Inc. Exhibit 113: Teleflex Inc. - Overview Exhibit 114: Teleflex Inc. - Business segments Exhibit 115: Teleflex Inc. - Key news Exhibit 116: Teleflex Inc. - Key offerings Exhibit 117: Teleflex Inc. - Segment focus 10.11 Urologix LLC Exhibit 118: Urologix LLC - Overview Exhibit 119: Urologix LLC - Product / Service Exhibit 120: Urologix LLC - Key offerings 10.12 Vendor Credentialing Service LLC dba symplr Exhibit 121: Vendor Credentialing Service LLC dba symplr - Overview Exhibit 122: Vendor Credentialing Service LLC dba symplr - Product / Service Exhibit 123: Vendor Credentialing Service LLC dba symplr - Key offerings 11 Appendix 11.1 Scope of the report 11.2 Inclusions and exclusions checklist Exhibit 124: Inclusions checklist Exhibit 125: Exclusions checklist 11.3 Currency conversion rates for US$ Exhibit 126: Currency conversion rates for US$ 11.4 Research methodology Exhibit 127: Research methodology Exhibit 128: Validation techniques employed for market sizing Exhibit 129: Information sources 11.5 List of abbreviations Exhibit 130: List of abbreviations About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio

NEW YORK, June 28, 2022 /PRNewswire/ -- As per Zion Market Research study, The size of the global pigmentation disorder treatment market is expected to attain a value of USD 8.90 billion by 2028, growing at a 5.75% CAGR during the forecast period from USD 6.01 billion in 2021. Key Industry Insights & Finding of the Pigmentation Disorder Market Reports: As per the analysis shared by our research analyst, the Pigmentation Disorder Market is expected to grow annually at a CAGR of around 5.75 % (2022-2028). Through the primary research, it was established that the Pigmentation Disorder Market was valued approximately USD 6.01 Billion in 2021 and is projected to reach to roughly USD 8.90 Billion by 2028. In North America, there are well established medical structure and large market companies that provide efficient treatment choices for individuals with post-inflammatory hyperpigmentation. Given the cultural preference for spotless and clear skin, Asian countries such as South Korea, China, Japan, and others, have an established market for pigmentation disorder treatment. Pigmentary dermatomes are also the second and fifth most frequent dermatomes among Blacks and Hispanics, correspondingly. Zion Market Research published the latest report titled as "Pigmentation Disorder Treatment Market By Treatment (Chemical Peels, Microdermabrasion, Topical Drugs, Phototherapy, Laser Therapy, Skin Grafting, Drugs, & Others), By End User (Dermatology Centers, Hospitals, & Aesthetic Clinics) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028." into their research database. Pigmentation Disorder Market : Overview Pigmentation is a skin condition caused by high quantities of melanin, a pigment produced by melanocytes. The amino acid tyrosine is oxidized, resulting in the formation of melanin. Melanin is carried by keratinocytes and, while it is innocuous, it dulls the skin. It mostly affects the face, although it could also impact various regions of the body. Whenever melanocytes are harmed, the body's melanin synthesis varies. The skin blackens or lightens as a result of this condition. The formation of melanin causes the skin to darken, while reduced synthesis of melanin causes the skin to lighten. Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): Our Free Sample Report Includes: 2022 Updated Report Introduction, Overview, and In-depth industry analysis COVID-19 Pandemic Outbreak Impact Analysis Included 160 + Pages Research Report (Inclusion of Updated Research) Provide Chapter-wise guidance on Request 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends Includes Updated List of tables & figures Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis Zion Market Research methodology Industry Dynamics: Pigmentation Disorder Market : Growth Drivers Increase in skin pigmentation disorders to drive the market growth. Dark-skinned individuals have a high frequency of pigmentary diseases. Pigmentary dermatomes are also the second and fifth most frequent dermatomes among Blacks and Hispanics, correspondingly. Increased sun exposure, rise in global warming, and the increases incidence of harmful sun rays due to environmental degradation are contributing factors to rise in pigmentary disorders. As a result, the global pigmentation disorder treatment market is predicted to grow due to the increased frequency of pigmentation disorders. Pigmentation Disorder Market : Restraints Lack of reimbursement policies for pigmentation treatment to affect the market negatively. In general case, insurance, or reimbursement is provided for medical expenses and treatments. But in the case of pigmentation disorders and its treatments, it is not covered under any policy. Only individuals from the higher economic segment of the society can afford such procedures, without any support of insurance. As a result, this causes a restraint for the growth of global pigmentation disorder treatment market. Directly Purchase a Copy of the Report @ Pigmentation Disorder Market: Opportunities Improvements in tissue engineering to open avenues for new procedures. Developments such as artificial skin drafts and engineered skin have evolved in the market. This not only helps in pigmentation disorders but also helps in wound healing. These skins are made out of artificial and natural materials, such as xenogenic, synthetic, allograft or autologous sources. This opens up new avenues for pigmentation treatments, given more research is conducted. This provides new opportunities for global market. Pigmentation Disorder Market: Challenges High cost of cosmetic treatments to pose as a challenge for the market. Though tremendous development in the pigmentation treatment market boosted the market opportunities, the cost of these procedures are expensive. The only affordable treatment for the masses is OTC or tropical medications. But the efficiency of these treatments is very less in comparison to other alternatives. High prices pose a threat to the global pigmentation disorder treatment market growth. Global Pigmentation Disorder Market : Segmentation The market is divided on the basis of treatment, end-user, and region. By treatment, the market is segregated into chemical peels, microdermabrasion, topical drugs, phototherapy, laser therapy, skin grafting, drugs, & others. Due to the better clinical studies in individuals with pigmentation disorders, the topical therapy category dominates the overall market. Azelaic acid, L-ascorbic acid, hydroquinone, and other topical medicines are the most commonly recommended worldwide. Topical therapy involves administering lotions, serums, creams, and ointments to the skin, which are prepared with various active components to treat specific pigmentation problems. The market, by end user, is classified as dermatology centers, hospitals, & aesthetic clinics. In the end user segment, inclination towards aesthetic procedures is expected to increase the market of aesthetic or cosmetic institutions. On the other hand, due to affordability, people are also expected to opt for OTC medications for home treatments. Get More Insight before [email protected] : List of Key Players of Pigmentation Disorder Market : Episciences Inc. Bayer AG La Roche-Posay Alvogen Inc. Obagi Medical Products Inc. Allergan Inc. Pierre Fabre Laboratories SkinCeuticals International. Key questions answered in this report: What are the growth rate forecast and market size for Pigmentation Disorder Market ? What are the key driving factors propelling the Pigmentation Disorder Market forward? What are the most important companies in the Pigmentation Disorder Market Industry? What segments does the Pigmentation Disorder Market cover? How can I receive a free copy of the Pigmentation Disorder Market sample report and company profiles? Report Scope: Free Brochure: Regional Dominance: North America to lead the global market during the forecast period. Because of the increased prevalence of pigmentation issues, North America leads the global pigmentation disorder treatment market. In North America, there are well established medical structure and large market companies that provide efficient treatment choices for individuals with post-inflammatory hyperpigmentation. Given the cultural preference for spotless and clear skin, Asian countries such as South Korea, China, Japan, and others, have an established market for pigmentation disorder treatment. Though given the prominence of several existing companies, the competition is tough in these regions. Global Pigmentation Disorder Market is segmented as follows: Pigmentation Disorder Market : By Treatment Outlook (2022-2028) Chemical Peels Microdermabrasion Topical Drugs Phototherapy Laser Therapy Skin Grafting Drugs Others Pigmentation Disorder Market : By End User Outlook (2022-2028) Dermatology Centers Hospitals Aesthetic Clinics Pigmentation Disorder Market : By Region Outlook (2022-2028) North America The U.S. Canada Europe France The UK Spain Germany Italy Rest of Europe Asia Pacific China Japan India South Korea Southeast Asia Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa GCC South Africa Rest of Middle East & Africa Press Release For Pigmentation Disorder Market : Browse Other Related Research Reports from Zion Market Research Orthopedic Soft Tissue Repair Market - Global Industry Analysis : The global Orthopedic Soft Tissue Repair Market accrued earnings worth approximately 5.7 (USD Billion) in 2020 and is predicted to gain revenue of about 11.2 (USD Billion) by 2028, is set to record a CAGR of nearly 6.4% over the period from 2021 to 2028. Dental Services Market - Global Industry Analysis : The global Dental Services Market accrued earnings worth approximately 302.4 (USD Billion) in 2020 and is predicted to gain revenue of about 556.3 (USD Billion) by 2028, is set to record a CAGR of nearly 6.5% over the period from 2021 to 2028. Surgical Drainage Devices Market - Global Industry Analysis : The global Surgical Drainage Devices Market accrued earnings worth approximately 1.12 (USD Billion) in 2020 and is predicted to gain revenue of about 3.20 (USD Billion) by 2028, is set to record a CAGR of nearly 5.7% over the period from 2021 to 2028. Browse through Zion Market Research's coverage of the Global Healthcare Industry Follow Us on: LinkedIn | Twitter | Facebook About Us Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us . Contact Us: Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll Free No.1-855-465-4651 Email: [email protected] Website: Blog : Logo: SOURCE Zion Market Research